Zai Lab H1 FY26 net loss widens 14% to USD 101.8 million; revenue falls 5% to USD 205.92 million - ZLAB News | RalliesZai Lab H1 FY26 net loss widens 14% to USD 101.8 million; revenue falls 5% to USD 205.92 million
Z
ZLAB• First-half results
- Zai Lab posted a U.S. GAAP net loss of USD 101.8 million, widening 14%, as revenue fell 5% to USD 205.9 million.
- Net product revenue slipped 6% to USD 201.3 million; ZEJULA dropped 31% to USD 62 million, VYVGART fell 7% to USD 41.4 million.
- XACDURO more than doubled to USD 16.5 million; NUZYRA rose 13% to USD 33.4 million, partially offsetting declines.
- R&D expenses climbed 14% to USD 127.4 million due to higher licensing fees; operating loss widened 31% to USD 145.9 million.
- KarXT launched in mainland China in June 2026; cash, cash equivalents, and restricted cash totaled USD 708.6 million at June 30, 2026.
